Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)
The Influence of Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Patients With Chronic Obstructive Pulmonary Disease
Sponsor: American Heart Association
Terminated
Funding was inconsistent and the Post-Doc left before the project ended
Other terminated trials from American Heart Association
Other Chronic Obstructive Pulmonary Disease trials with similar outcome
This EARLY_PHASE1 trial investigates Chronic Obstructive Pulmonary Disease and is currently terminated or withdrawn. American Heart Association leads this study, which shows 10 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Mar 2025 — Present [monthly]
Terminated EARLY_PHASE1
Status: Recruiting → Terminated
-
Sep 2024 — Mar 2025 [monthly]
Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting EARLY_PHASE1
-
May 2024 — Jul 2024 [monthly]
Recruiting EARLY_PHASE1
Phase: NA → EARLY_PHASE1
-
Feb 2024 — May 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Nov 2023 — Feb 2024 [monthly]
Recruiting NA
-
Apr 2023 — Nov 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2023 — Apr 2023 [monthly]
Not Yet Recruiting NA
-
Jan 2023 — Feb 2023 [monthly]
Not Yet Recruiting NA
-
Dec 2022 — Jan 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- American Heart Association
- Virginia Commonwealth University
For direct contact, visit the study record on ClinicalTrials.gov .